Why Tirzepatide.
Dual GIP + GLP-1 receptor action
Superior weight loss vs. GLP-1 monotherapy
Improved insulin sensitivity
Once-weekly subcutaneous injection
About Tirzepatide.
Tirzepatide is a first-in-class dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. By targeting two incretin pathways simultaneously, it achieves greater weight reduction than GLP-1 monotherapy, with significant metabolic and cardiovascular benefits.
How it works.
From intake to your first dose — four straightforward steps.
Complete intake
A brief health questionnaire reviewed by our clinical team. Takes about 5 minutes.
Provider review
A board-certified clinician reviews your history within 48 hours.
Compounded & shipped
Your prescription is compounded in a licensed US pharmacy and shipped to your door.
Ongoing support
Telehealth follow-up to adjust your protocol as needed.
Ready to start Tirzepatide?
Complete a brief health intake and a licensed provider will review your request within 48 hours. No commitments.
All prescriptions are issued at the sole discretion of licensed providers. Protocol Health Rx does not guarantee prescription approval.